No. 1
Bluehill.VC
1Rounds led
Led or co-led 1 of the 4 BioTech rounds in The Sync Report.
- Helex secures $3.5 million to advance next-gen gene therapies for kidney diseasesSeed · $3.5 million
Sector desk
Every BioTech round in The Sync Report, and the investors leading them.
By stage
From InvestorDB
No. 1
Led or co-led 1 of the 4 BioTech rounds in The Sync Report.
Filter InvestorDB by BioTech focus, stage and geography, then build your shortlist.
Open InvestorDB